Important Information Regarding PegIntron®(peginterferon alfa-2b) single dose REDIPEN® and INTRON A® (interferon alfa-2) Multidose REDIPEN

SOL Limited (Singapore Branch), a subsidiary of Merck & Co. Inc., would like to inform healthcare professionals of the market recall of alcohol prep pads manufactured by the Triad Group which are co-packaged with MSD products PegIntron® (peginterferon alfa-2b) and INTRON A® (interferon alfa-2). The recall was initiated due to potential contamination of the prep pads with the bacteria, Bacillus cereus. Healthcare professionals are advised to discard the alcohol prep pads found in the medicine package of PegIntron® single dose REDIPEN®, PegIntron® vials, INTRON A® multidose REDIPEN® and INTRON A® Solution vials and to inform their patients to do likewise.

 
 
Healthcare professional, Therapeutic Products
Published:

Dear Healthcare Professional Letters

12 Dec 2019

Only abstracts of the Dear Healthcare Professional Letters (DHCPL) are provided on this website. Details of the letters can be found on the MOH Alert System, which is accessible via the Health Professionals Portal (HPP). HPP is a one-stop portal for all healthcare professionals in Singapore. Dentists, medical doctors and pharmacists may access HPP at https://www.hpp.moh.gov.sg/, and follow the procedures below to access the MOH Alert system.

Step 1: Scroll down to the bottom navigation panel of the HPP web page. Under the Healthcare Professionals section, expand the dropdown option for ‘Healthcare Professional Portal’ and select your profession. You will be redirected to the specific HPP web page to log in.

Step 2: Click on the Restricted Content icon on the left panel of the web page and log in via SingPass.

Step 3: Click on the MOH Alert icon under the ‘Applications’ section.

Step 4: Click on the Drug Alert tab to view the DHCPLs.